In a 15‑year‑old with restless‑legs syndrome and microcytic hypochromic anemia, does a ferritin level of 174 ng/mL require iron supplementation?

Iron Supplementation for a 15-Year-Old with RLS and Ferritin 174 ng/mL

Yes, iron supplementation is indicated for this adolescent with restless legs syndrome despite a ferritin level of 174 ng/mL, because pediatric RLS guidelines recommend iron supplementation for ferritin levels below 50 ng/mL, and this patient also has microcytic hypochromic anemia requiring treatment. 1

Pediatric-Specific Iron Thresholds for RLS

The 2025 American Academy of Sleep Medicine guidelines establish fundamentally different iron supplementation thresholds for children compared to adults with RLS 1:

• Children with RLS should receive iron supplementation when serum ferritin is <50 ng/mL (using oral or IV formulations) 1
• This threshold is substantially lower than the adult RLS threshold of ≤75 ng/mL for oral iron or 75-100 ng/mL for IV iron 1
• The AASM conditionally recommends ferrous sulfate for children with RLS who have "appropriate iron status" (very low certainty of evidence) 1

Critical Context: Microcytic Hypochromic Anemia

The presence of microcytic hypochromic anemia fundamentally changes this clinical scenario beyond RLS management alone. This finding indicates true iron deficiency requiring treatment regardless of the ferritin level 2:

• Microcytic hypochromic red blood cells are a direct manifestation of inadequate iron for hemoglobin synthesis
• Ferritin can be falsely elevated by inflammation, infection, or acute phase responses, masking underlying iron deficiency 2, 3
• A ferritin of 174 ng/mL in the context of microcytic hypochromic anemia suggests either concurrent inflammation elevating ferritin or functional iron deficiency 4

Recommended Diagnostic Workup

Before initiating iron therapy, obtain complete iron studies in the morning after avoiding iron-containing supplements and foods for at least 24 hours 1:

• Transferrin saturation (calculated from serum iron and total iron binding capacity) - target <20% indicates need for supplementation 1
• Complete blood count with red cell indices to characterize the anemia
• Consider inflammatory markers (CRP, ESR) if ferritin seems discordantly elevated relative to the microcytic anemia 2

Treatment Approach

First-Line: Oral Iron Supplementation

Initiate ferrous sulfate 65 mg elemental iron daily or every other day 1, 5:

• Oral iron is the conditional recommendation for pediatric RLS 1
• Take on an empty stomach for optimal absorption, or with meals if not tolerated 2
• Adding 500 mg vitamin C enhances absorption 2
• Monitor for constipation, the most common limiting side effect in children 1

Consider IV Iron If:

IV iron formulations may be necessary if 1:

• Oral iron is not tolerated due to gastrointestinal side effects
• Ferritin fails to improve after 3-6 months of oral supplementation
• Severe anemia requires more rapid repletion
• Malabsorption is suspected (though less common in adolescents without gastrointestinal disease)

Address Exacerbating Factors

The first step in RLS management involves identifying and eliminating exacerbating factors 1:

• Caffeine and alcohol consumption
• Antihistaminergic medications (particularly diphenhydramine) 5
• Serotonergic antidepressants 5
• Antidopaminergic medications
• Screen for and treat obstructive sleep apnea if present 1

Monitoring and Follow-Up

Recheck serum ferritin and transferrin saturation every 3-6 months during iron therapy 6:

• Target ferritin >50 ng/mL for pediatric RLS 1
• Ensure transferrin saturation >20% 1
• Monitor complete blood count to document resolution of microcytic hypochromic anemia
• Assess RLS symptom improvement using validated scales

Important Caveats

The ferritin level of 174 ng/mL appears paradoxically elevated given the microcytic hypochromic anemia 4:

• This discordance suggests either inflammation elevating ferritin or a measurement artifact 7, 4
• Different ferritin assays yield varying absolute values (Beckman vs. Roche methods can differ by 50-60% at equivalent iron stores) 7
• Transferrin saturation provides critical confirmatory information in this scenario 1, 4
• Do not withhold iron supplementation based solely on ferritin when microcytic hypochromic anemia is present 2, 4

Avoid dopamine agonists as first-line therapy in this adolescent 1:

• The 2025 AASM guidelines now recommend against standard use of dopamine agonists (pramipexole, ropinirole, rotigotine) due to augmentation risk 1
• Augmentation occurs in 7-10% annually and is associated with low ferritin levels 5, 8
• If pharmacologic therapy beyond iron is needed, gabapentinoids are first-line 1